Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

• Päätekijät: Yongji Wang (Tekijä), Yangyang Qi (Tekijä), Wenguo Xu (Tekijä), Yuansheng Hu (Tekijä), Ling Wang (Tekijä), Yongpei Yu (Tekijä), Zhiwei Jiang (Tekijä), Jielai Xia (Tekijä), Gang Zeng (Tekijä), Yalong Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2020-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, randomized, open-label clinical trial was performed...